Our
Media
Find recent and archived press releases, and discover the latest news about our company, our investments, and our people.
Rhia In The Press
News
DECEMBER 19, 2024
Call for Applications: Community Advisory Council
Rhia Ventures is forming an advisory body to ensure our accountability to the communities and movements we aim to serve.
NOVEMBER 13, 2024
Rhia Ventures and Adasina Social Capital Announce Next Steps toward Increasing Racial Equity in Investment Decision-Making
The Due Diligence 2.0 Commitment brings overdue innovation to asset management industry standards for risk assessment and stimulates capital flow to underrepresented asset managers.
SEPTEMBER 23, 2024
Team Transition Seizes on Market Shift in Women’s Health Investment
Departing RH Capital fund managers have launched an independent venture firm to continue supporting women’s health startups.
JUNE 28, 2024
Rhia Ventures Comments on Supreme Court’s Decision to Allow Emergency Abortions in Idaho
The ruling fails to resolve the conflict between a state abortion ban and federal law protecting access to stabilizing emergency medical treatment.
JUNE 14, 2024
Rhia Ventures Shares Statement on Supreme Court’s Mifepristone Decision
The decision by the highest court rejects the attempt to undo FDA’s approval and allows mifepristone to be available via telehealth.
JULY 12, 2023
Rhia Ventures Responds to Meta’s Call for Public Comment on Moderation of Posts Relating to Abortion
Meta has continued to remove abortion-related content without providing sufficient transparency as to why it violates the company’s community guidelines.
APRIL 24, 2023
Rhia Ventures Issues Statement on Supreme Court’s Mifepristone Decision
The decision by the highest court to leave the FDA’s approval in place allows mifepristone to remain on the market, for now.
APRIL 8, 2023
Rhia Ventures Issues Statement on Mifepristone Rulings
Conflicting federal rulings on the legal status of mifespristone further complicate the legal landscape of abortion care in the US.
JANUARY 24, 2023
Shareholders File Numerous Proposals Addressing Access to Reproductive Health Care for 2023 Proxy Ballots
In coordination with Rhia Ventures, investors have filed thirty-one (31) shareholder proposals addressing the intersections between corporate policy and reproductive health care, more than doubling the volume of last year’s activity.
JANUARY 14, 2022
Shareholder Proposals Challenge Companies on Support for Politicians Opposing Abortion Access, Progress on Climate, Voting Rights
Institutional investors, in coordination with Rhia Ventures, have filed 11 shareholder proposals for the 2022 proxy season that address the misalignment between corporation’s stated values and their support for politicians and political groups who undermine them.
April 13, 2021
Shareholders Challenge Pfizer, The Home Depot, and JPMorgan Chase on Values Misalignment: Proposals Say Political Spending and Corporate Values Are at Odds
Company reputation is at risk in real time; backlash rising against companies’ support for politicians who back voter suppression, embrace the “stolen election” narrative, restrict access to healthcare, and take other ill-advised stands.
JANUARY 21, 2020
Report: Comprehensive Reproductive Health Care Essential for Employees and Corporate America’s Bottom Line
A groundbreaking new report, that connects how access to comprehensive reproductive health care impacts a company’s bottom line and the corporate workforce.
